tiprankstipranks
Phasebio Pharmaceuticals, Inc. (PHASQ)
:PHASQ
US Market
Holding PHASQ?
Track your performance easily

Phasebio Pharmaceuticals (PHASQ) Stock Price & Analysis

Followers

PHASQ Stock Chart & Stats


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

PHASQ FAQ

What was Phasebio Pharmaceuticals, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Phasebio Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Phasebio Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Phasebio Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Phasebio Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Phasebio Pharmaceuticals, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Phasebio Pharmaceuticals, Inc. pay dividends?
    Phasebio Pharmaceuticals, Inc. does not currently pay dividends.
    What is Phasebio Pharmaceuticals, Inc.’s EPS estimate?
    Phasebio Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Phasebio Pharmaceuticals, Inc. have?
    Currently, no data Available
    What happened to Phasebio Pharmaceuticals, Inc.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Phasebio Pharmaceuticals, Inc.?
    Currently, no hedge funds are holding shares in PHASQ
    ---
    Popular Stocks
    ---
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis